Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: New Constructs, LLC
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Derma Sciences Inc gives FY 2013 revenue guidance below analysts' estimates

Thursday, 16 Jan 2014 07:00am EST 

Derma Sciences Inc:Sees total revenue for FY 2013 to be $79.7 million.FY 2013 revenues of $82.4 million - Thomson Reuters I/B/E/S Estimates. 

Company Quote

-0.14 -1.66%
9:50am EST